BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin widens to 59.2%
Gross margin was 59.2% in Q1 FY2026, up 0.7 pp from a year earlier. On a trailing-twelve-month basis it was 59.5%, up 3.4 pp year over year. Over 3 fiscal years it widened by 37.2 pp.
Context
- Gross margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 59.3%
- Year-over-year change
- +4.0pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 59.3% | +4.0pp |
| FY2024 | 2024-12-31 | 55.4% | +10.9pp |
| FY2023 | 2023-12-31 | 44.5% | +22.3pp |
| FY2022 | 2022-12-31 | 22.2% | -9.7pp |
| FY2021 | 2021-12-31 | 31.9% | — |
Gross Margin vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 gross margin of 59.5% is the highest of the 8 companies compared; the peer median is 17.6%.
- Its year-over-year change of +3.4 pp is the 3rd highest of 8, against a peer median of -1.8 pp.
- Over three fiscal years its change of +37.2 pp compares with a peer median of -10.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 59.5% | +3.4 pp | +37.2 pp | |
| LTM May 2025 | 38.5% | -2.7 pp | -19.5 pp | |
| LTM Mar 2026 | 29.8% | +9.3 pp | -10.9 pp | |
| LTM Mar 2026 | 21.8% | +5.9 pp | +6.1 pp | |
| LTM Mar 2026 | 17.6% | -0.5 pp | +3.5 pp | |
| LTM Mar 2026 | 8.4% | -1.8 pp | -4.4 pp | |
| LTM Mar 2026 | -3.7% | -12.3 pp | -25.5 pp | |
| LTM Mar 2026 | -26.9% | -26.7 pp | -49.8 pp | |
USGOU.S. GoldMining Inc. | FY2025 | — | — | — |
| Peer median (excluding BHST) | 17.6% | -1.8 pp | -10.9 pp | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.1M | 5.5M | 12.67M | 25.19M | 34.51M |
| Cost of Revenue | 1.43M | 4.28M | 7.04M | 11.25M | 14.03M |
| Gross Profit | 670K | 1.22M | 5.63M | 13.94M | 20.48M |
| Gross Margin | 31.9% | 22.2% | 44.5% | 55.4% | 59.3% |
| Research & Development | 4.13M | 2.31M | 3.37M | 4.8M | 5.31M |
| Selling, General & Admin | 4.76M | 9.35M | 12.08M | 14.67M | 19.14M |
| Operating Expenses | 9.16M | 11.83M | 15.6M | 20.93M | 26.05M |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| EBITDA | (8.64M) | (9.13M) | (9.76M) | (9.72M) | (6.71M) |
| EBITDA Margin | -410.9% | -166.0% | -77.0% | -38.6% | -19.5% |
| Operating Income | (8.49M) | (10.61M) | (9.97M) | (6.99M) | (5.58M) |
| Operating Margin | -403.9% | -193.0% | -78.6% | -27.7% | -16.2% |
| Interest Income | 0 | 0 | 0 | 0 | 54K |
| Interest Expense | 805K | 1.4M | 1.96M | 1.93M | 2.72M |
| Other Income / Expenses | (1.34M) | (624K) | (2.6M) | (5.92M) | (5.48M) |
| Income Before Tax | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.06M) |
| Pre-Tax Margin | -467.5% | -204.4% | -99.1% | -51.2% | -32.0% |
| Income Tax Expense | 0 | 0 | 0 | 8K | 76K |
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Net Margin | -467.5% | -204.4% | -99.1% | -51.3% | -32.3% |
| EPS (Basic) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| EPS (Diluted) | (0.70) | (0.70) | (0.93) | (0.80) | (0.60) |
| Weighted Avg Shares | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
| Weighted Avg Shares (Diluted) | 12.45M | 13.05M | 13.53M | 16.19M | 18.41M |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.